Biomimetic Ceramic Composite: Characterization, Cell Response, and In Vivo Biocompatibility

• Published in: Materials Vol. 14; no. 23; p. 7374
• Main Authors: Lin, Hung-Yang, Lu, Yi-Jung, Chou, Hsin-Hua, Ou, Keng-Liang, Huang, Bai-Hung, Lan, Wen-Chien, Saito, Takashi, Cho, Yung-Chieh, Ou, Yu-Hsin, Yang, Tzu-Sen, Peng, Pei-Wen
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01-12-2021; MDPI
• Subjects: Biocompatibility; Biomimetics; Calcium phosphates; Carbon dioxide; Cytotoxicity; Fourier transforms; Grafting; Heat; Heat treatment; Hydroxyapatite; In vivo methods and tests; Infrared spectroscopy; Morphology; Raman spectroscopy; Scanning electron microscopy; Skin & tissue grafts; Spectrum analysis; Substitute bone; Synthesis; Toxicity; United States > US; Japan; Taiwan
• ISSN: 1996-1944; 1996-1944
• DOI: 10.3390/ma14237374

The present study aimed to synthesize biphasic calcium phosphate ceramics (CaPs) composed of β-tricalcium phosphate (β-TCP) and hydroxyapatite (HAp) from the propagated Scleractinian coral and dicalcium phosphate anhydrous using a solid-state reaction followed by heat treatment at a temperature of 1100 °C for 1 h to 7 days. The as-prepared coral and coral-derived biphasic CaPs samples were characterized through scanning electron microscopy, X-ray diffractometry, Fourier transform infrared spectroscopy, and Raman spectroscopy. The cell response of the biphasic CaPs was evaluated by in vitro cytotoxicity assessment using mouse fibroblast (L929) cells. The bilateral femoral defect rabbit model was used to assess the early local reaction of the coral-derived biphasic CaPs bone graft on tissue. The results confirmed that the co-existence of β-TCP and HAp was formed at 1100 °C for 1 h. The ratio of HA/β-TCP increased as the heat-treatment time increased. The coral-derived biphasic CaPs comprising 61% HAp and 39% β-TCP (defined as HT-3) were not cytotoxic. Furthermore, no significant differences in local tissue reaction were observed between the HT-3 sample and autogenous bone. Therefore, the synthesized coral-derived biphasic CaPs is a candidate for bone grafting due to its good biocompatibility.